The purpose of this study is to assess the relationship between magnetic resonance images (MRI) of the hypothalamic–pituitary (H-P) region and response to recombinant human growth hormone (rhGH) treatment in short children with growth hormone deficiency, basing on changes of auxologic parameters, as well as to answer the question if MRI may serve for selecting and monitoring the rhGH responders.
The study group comprised 85 children treated with rhGH, aged 7.3–18.7 years, followed for the mean period of 3.2 years (range, 2.1–9.5 years). Auxologic parameters (height deficit hSDS, deviation from the mid-parental height hSDS–mpSDS, bone delay index bone age/chronological age ratio (BA/CA)) were assessed before, during and at the end of rhGH treatment; growth velocity was calculated before and during rhGH therapy. Parameters were correlated with the MRI of the H-P region.
Structural anomalies of the H-P region were found in 22 (25.9%) children: empty sella syndrome (ESS) in 12 (14.1%) patients, ectopic posterior pituitary (EPP) in ten (11.8%). Patients’ height deficit and their deviation from parental height before rhGH therapy was significantly greater in the EPP group (median hSDS = −3.8; hSDS–mpSDS = −2.5), bone age delay was the greatest in the ESS group (median BA/CA = 0.69), after therapy – in the EPP group (median BA/CA = 0.82). Growth velocity improved in the first year of the rhGH therapy in all groups; however, the most significant acceleration was observed in the EPP group (median delta hSDS = 0.9), then stabilised and was comparable in all groups.
MRI may be helpful in predicting response to the rhGH treatment, providing midline abnormalities are taken into account.
Argente J, Abusrewil SA, Bona G, Chiarelli F, Kelnar CJ, Skordis N (2001) International workshop on management of puberty for optimum auxological results isolated growth hormone deficiency in children and adolescents. J Pediatr Endocrinol Metab 14(suppl 2):1003–1008 PubMed
Bozzola M, Adamsbaum C, Biscaldi I, Zecca M, Cisternino M, Genovese E, Richard I, Kalifa G, Chaussain JL (1996) Role of magnetic resonance imaging in the diagnosis and prognosis of growth hormone deficiency. Clin Endocrinol (Oxf) 45:21–6 CrossRef
Castillo M (2005) Pituitary gland: development, normal appearances and Magnetic Resonance imaging protocols. Top Magn Reson Imaging 4:259–268 CrossRef
Chen S, Leger J, Garel C, Hassan M, Czernichow P (1999) Growth hormone deficiency with ectopic neurohypophysis: anatomical variations and relationship between the visibility of the pituitary stalk asserted by magnetic resonance imagining and anterior pituitary function. J Clin Endocrinol Metab 84:2408–2413 PubMedCrossRef
de Marinis L, Bonadonna S, Bianchi A, Maira G, Giustina A (2005) Primary empty sella. J Clin Endocrinol Metab 91:3329–3336
Elster AD (1993) Modern imaging of the pituitary. Radiology 187:1–14 PubMed
Greulich WW, Pyle SI (eds) (1959) Radiographic atlas of skeletal development of the hand and wrist, 2nd edn. Stanford University Press, Stanford
Hilczer M, Smyczyńska J, Lewinski A (2006) Limitations of clinical utility of growth hormone stimulating tests in diagnosing children with short stature. Endocr Regul 40:69–75 PubMed
Kalina M, Kalina-Faska B, Gruszczyńska K, Januszek-Trzciąkowska A, Kluczewska E, Małecka-Tendera E (2007) Relationship between magentic resonance image of the pituitary gland and growth hormone concentrations in short-stature children with growth hormone deficiency. Endokrynol Pediatr 6:35–44
Maghnie M, Salati B, Bianchi S, Rallo M, Tinelli C, Autelli M, Aimaretti G, Ghigo E (2001) Relationship between the morphological evaluation of the pituitary and the growth hormone (GH) response to GH-releasing hormone plus arginine in children and adults with congenital hypopituitarism. J Clin Endocrinol Metab 86:1574–1579 PubMedCrossRef
Maghnie M, Ambrosini L, Cappa M, Pozzobon G, Ghizzoni L, Ubertini MG, di Iorgi N, Tinelli C, Pilia S, Chiumello G, Lorini R, Loche S (2006) Adult height in patients with permanent growth hormone deficiency with and without multiple pituitary hormone deficiencies. J Clin Endocrinol Metab 91:2900–2950 PubMedCrossRef
Palczewska J, Niedźwiecka Z (2001) Wskaźniki rozwoju somatycznego dzieci i młodzieży warszawskiej. Med Wieku Rozw 2 (suppl 1):55–56, 113–114
Tillmann V, Tang VW, Price DA, Hughes DG, Wright NB, Clayton PE (2000) Magnetic resonance imaging of the hypothalamic-pituitary axis in the diagnosis of growth hormone deficiency. J Pediatr Endocrinol Metabol 13:1577–1583 CrossRef
Triulzi F, Scotti G, di Natale B, Pellini C, Lukezic M, Scognamiglio M, Chiumello G (1994) Evidence of a congenital midline brain anomaly in pituitary dwarfs: a magnetic resonance imaging study in 101 patients. Pediatrics 93:409–416 PubMed
Voutetakis A, Sertedaki A, Livadas S, Xekouki P, Bossis I, Dacou-Voutetakis C, Argyropoulou MI (2006) Pituitary size fluctuation in long-term MR studies of PROP1 deficient patients: a persistent pathophysiological mechanism? J Endocrinol Invest 29:462–466 PubMed
Zenaty D, Garel C, Limoni C, Czernichow P, Leger J (2003) Presence of magnetic resonance imagining abnormalities of the hypothalamic-pituitary axis is a significant determinant of the first 3 years growth response to human growth hormone treatment in prepubertal children with nonaquired growth hormone deficiency. Clin Endocrinol (Oxf) 58:647–652
- Usefulness of magnetic resonance findings of the hypothalamic-pituitary region in the management of short children with growth hormone deficiency: evidence from a longitudinal study
Maria A. Kalina
Neu im Fachgebiet Chirurgie
e.Med Kampagnen-Visual, Mail Icon II